Mechanisms of isoniazid resistance in Mycobacterium tuberculosis: Enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 769-775

  Basso, Luiz A ^b   Zheng, Renjian ^b   Musser, James M ^b   Jacobs Jr , William R ^b   Blanchard, John S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIENOYL COENZYME A REDUCTASE (NADPH); ACYL CARRIER PROTEIN; ISONIAZID; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BACTERIUM MUTANT; ENZYME BINDING; ENZYME INACTIVATION; ENZYME KINETICS; ESCHERICHIA COLI; MISSENSE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURAL GENE; TUBERCULOSIS;

EID: 0031689089     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515362     Document Type: Article

References (10)

1. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-64.
2. Heym B, Honoré N, Truffot-Pernot C, et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 1994;344:293-8.
3. Kritski AL, Marques MJO, Rabahi MF, et al. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 1996; 153:331-5.
4. Ristow M, Möhlig M, Rifai M, et al. New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet 1995;346:502-3.
5. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
6. Morris S, Bai GH, Suffys P, Portillo-Gomez L, Fairchock M, Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 1995; 171:954-60.
7. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8:496-514.
8. Berstein J, Lott WA, Steinberg BA, Yale HL. Chemotherapy of experimental tuberculosis. Am Rev Tuberc 1952; 65:357-64.
9. Middlebrook G. Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am Rev Tuberc 1952;65:765-7.
10. Takayama K, Wang L, David HL. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1972;2:29-35.